CD4 and neoplasm: It may be speculated that the more diversified clonal CD4+ T-cell responses in our TCR analyses reflect the diversification of active antigen/neoantigen epitopes, i.e., tumor antigenicity that had actually stimulated T-cell responses in context of each patient's HLA haplotypes.